D61.1 vs D61.810
D61.1 (Drug-induced aplastic anemia) compared with D61.810 (Antineoplastic chemotherapy induced pancytopenia), from the official CMS tabular data. Both may be reported when both conditions are documented (Excludes2).
Can these codes be reported together?
Yes, when both are documented. D61.810 carries an Excludes2 note covering D61.1: “aplastic anemia due to antineoplastic chemotherapy (D61.1)”
Excludes2 marks distinct conditions — both may be reported when both are documented.
Side by side
| D61.1Drug-induced aplastic anemia | D61.810Antineoplastic chemotherapy induced pancytopenia | |
|---|---|---|
| Billing status | Billable | Billable |
| Classification | D50-D89 — Diseases of the Blood and Blood-forming Organs and Certain Disorders Involving the Immune Mechanism (D50-D89) | D50-D89 — Diseases of the Blood and Blood-forming Organs and Certain Disorders Involving the Immune Mechanism (D50-D89) |
| Definition | Drug-induced aplastic anemia is a billable ICD-10-CM diagnosis code (D61.1). | Antineoplastic chemotherapy induced pancytopenia is a billable ICD-10-CM diagnosis code (D61.810). |
| Use additional code | code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5) | — |
Derived from the official CMS ICD-10-CM tabular data (FY2026). Not billing advice; verify sequencing rules for the encounter. All data sources